Anthem Biosciences IPO : Key Performance Indicators, PE Ratio, EPS, ROE, ROCE & RoNW
The Company Key Performance Indicates the pre-issue EPS of ₹ 8.07 and post-issue EPS of ₹ 8.04 for FY24. The pre-issue P/E ratio is 70.63x, while the post-issue P/E ratio is 70.94x against the Industry P/E ratio is 81x. The company's ROCE for FY24 is 27.64%, ROE for FY24 is 20.82% and RoNW is 20.82%. These metrics suggest that the IPO is fairly priced.
Key Performance Indicator |
|||||||||||
| KPI | Values | ||||||||||
| EPS Pre IPO (Rs.) | ₹ 8.07 | ||||||||||
| EPS Post IPO (Rs.) | ₹ 8.04 | ||||||||||
| P/E Pre IPO | 70.63 | ||||||||||
| P/E Post IPO | 70.94 | ||||||||||
| ROE | 20.82 % | ||||||||||
| ROCE | 27.64 % | ||||||||||
| P/BV | 13.23 | ||||||||||
| Debt/Equity | 0.05 | ||||||||||
| RoNW | 20.82 % | ||||||||||
Stock Market Masterclass
Option Trading with CA Abhay
Stock Market Masterclass
Option Trading with CA Abhay
Copyright @2020 Design & Developed by Info Web Software